Recent Articles


Fundamental role of Methylenetetrahydrofolate reductase 677 c ? T genotype and Flavin compounds in Biochemical Phenotypes for schizophrenia and schizoaffective Psychosis

The Mental Health Biomarker Project (2010–2016) explored variables for psychosis in schizophrenia and schizoaffective disorder. Blood samples from 67, highly characterized symptomatic cases and 67 gender and age matched control participants were analyzed for methyl tetrahydrofolate reductase (MTHFR) 677C ? T gene variants and for vitamin B6, B12 and D, folate, unbound copper, zinc cofactors for enzymes in the methylation cycle, and related catecholamine pathways.

Read article >

Biomarker case-Detection and Prediction with Potential for Functional Psychosis screening: Development and Validation of a Model related to Biochemistry, sensory neural Timing & end Organ Performance

The Mental Health Biomarker Project aimed to discover case-predictive biomarkers for functional psychosis. In a retrospective, cross-sectional study, candidate marker results from 67 highly characterized symptomatic participants were compared with results from 67 gender- and age-matched controls.

Read article >

The Case for Mental Health Reform in Australia: a Review of Expenditure and System Design

Read article >

Role of magnesium supplementation in the treatment of depression: A randomized clinical trial

Abstract Current treatment options for depression are limited by efficacy, cost, availability, side effects, and acceptability to patients. Several studies have looked at the association between magnesium and depression, yet its role in symptom management is unclear.

Read article >

Micronutrient Therapy for Violent Aggressive Male Youth

Abstract Objectives: Pharmacotherapy for problematic aggressive and violent behavior disorders in male children and adolescents is associated with significant adverse events. Treatments with more acceptable risk–benefit ratios are critically needed. Micronutrient intervention will be investigated as an alternative to bridge the therapeutic gap in the management of these behaviors.

Read article >

N-acetylcysteine in psychiatry:current therapeutic evidence and potential mechanisms of action

Review Paper

Read article >

Clinical Trials of N-acetylcysteine in psychiatry and neurology

A systematic review

Read article >